S. BOZKURT Et Al. , "Immunohistochemical analysis of Calreticulin mutations in primary myelofibrosis (PRMF) patients: Results of our instution in the JAK2V617F mutated and JAK2V617F wild type PRMF patients," 22nd European hematology Association Congress June 22-25-2017 Madrid Absract PB2027 , Madrid, Spain, 2017
BOZKURT, S. Et Al. 2017. Immunohistochemical analysis of Calreticulin mutations in primary myelofibrosis (PRMF) patients: Results of our instution in the JAK2V617F mutated and JAK2V617F wild type PRMF patients. 22nd European hematology Association Congress June 22-25-2017 Madrid Absract PB2027 , (Madrid, Spain).
BOZKURT, S., GEÇGEL, F., ATAGÜNDÜZ, I., AGYAOL, Y., TURKÖZ, K., & TUĞLULAR, A. T., (2017). Immunohistochemical analysis of Calreticulin mutations in primary myelofibrosis (PRMF) patients: Results of our instution in the JAK2V617F mutated and JAK2V617F wild type PRMF patients . 22nd European hematology Association Congress June 22-25-2017 Madrid Absract PB2027, Madrid, Spain
BOZKURT, SÜHEYLA Et Al. "Immunohistochemical analysis of Calreticulin mutations in primary myelofibrosis (PRMF) patients: Results of our instution in the JAK2V617F mutated and JAK2V617F wild type PRMF patients," 22nd European hematology Association Congress June 22-25-2017 Madrid Absract PB2027, Madrid, Spain, 2017
BOZKURT, SÜHEYLA Et Al. "Immunohistochemical analysis of Calreticulin mutations in primary myelofibrosis (PRMF) patients: Results of our instution in the JAK2V617F mutated and JAK2V617F wild type PRMF patients." 22nd European hematology Association Congress June 22-25-2017 Madrid Absract PB2027 , Madrid, Spain, 2017
BOZKURT, S. Et Al. (2017) . "Immunohistochemical analysis of Calreticulin mutations in primary myelofibrosis (PRMF) patients: Results of our instution in the JAK2V617F mutated and JAK2V617F wild type PRMF patients." 22nd European hematology Association Congress June 22-25-2017 Madrid Absract PB2027 , Madrid, Spain.
@conferencepaper{conferencepaper, author={SÜHEYLA BOZKURT Et Al. }, title={Immunohistochemical analysis of Calreticulin mutations in primary myelofibrosis (PRMF) patients: Results of our instution in the JAK2V617F mutated and JAK2V617F wild type PRMF patients}, congress name={22nd European hematology Association Congress June 22-25-2017 Madrid Absract PB2027}, city={Madrid}, country={Spain}, year={2017}}